Skip to content

P K McGuire

3 papers in the library · publishing 2011-2015

Papers

Sort Most recent Most cited

Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis.

European Neuropsychopharmacology January 2015 Sagnik Bhattacharyya, Zerrin Atakan, Rocío Martín‐Santos et al.

Cannabis use can induce acute psychotic symptoms and increase the risk of schizophrenia. Impairments in inhibitory control and processing are known to occur both under the influence of cannabis and in schizophrenia. Whether cannabis-induced impairment in inhibitory processing is related to the acute induction of psychotic symptoms under its influence is unclear. We investigated the effects of...

Neuroimaging studies of acute effects of THC and CBD in humans and animals: a systematic review.

Current Pharmaceutical Design 2014 Albert Batalla, José A. Crippa, Geraldo F. Busatto et al.

In recent years, growing concerns about the effects of cannabis use on mental health have renewed interest in cannabis research. In particular, there has been a marked increase in the number of neuroimaging studies of the effects of cannabinoids. We conducted a systematic review to assess the impact of acute cannabis exposure on brain function in humans and in experimental animals. Papers...

Ketamine-induced disruption of verbal self-monitoring linked to superior temporal activation.

Pharmacopsychiatry January 2011 J M Stone, K M Abel, M P G Allin et al.

Misattribution of distorted self-generated speech in patients with schizophrenia has been associated with increased lateral temporal activation. As a pharmacological model of schizophrenia, we tested whether ketamine would induce the same effects in healthy individuals. Participants were 8 healthy male volunteers who were naïve to ketamine (mean age: 28 years). Ketamine (0.23 mg/kg bolus...